Table 4

Clinico-pathologic and genetic characteristics of EBV-GC

Birth year

Diagnostic year

Age

Gender

Lacation

Invasion

Histology Lauren/WHO

EBNA-3 type A/B

BamHI-F type F/"f"

BamHI-I type I/"i"

XhoI +/-


1

1949

1981

32

Male

Lower

Muscle

Diffuse/por1

A

F

"i"

+

2

1929

1982

53

Male

Middle

Muscle

Diffuse/por1

A

F

"i"

-

3

1928

1983

55

Male

Middle

Serosa

Intestinal/tub2

A

F

"i"

+

4

1928

1983

55

Male

Middle

Serosa

Diffuse/por2

A

F

I

+

5

1940

1983

43

Female

Lower

Muscle

Diffuse/por1

A

F

"i"

-

6

1930

1986

56

Male

Middle

Serosa

Diffuse/por2

A

ND1

"i"

+

7

1928

1988

60

Male

Upper

Serosa

Diffuse/por1

A

F

"i"

+

8

1928

2001

73

Male

Middle

Serosa

Difuse/por2

A

"f'

"i"

-

9

1953

2002

49

Male

Lower

Seroasa

Diffuse/por2

A

"f"

"i"

+


1Not determined; tub2: moderately differentiated adenocarcinoma por1: solid poorly differentiated adenocarcinoma; por2: non-solid poorly differentiated adenocarcinoma

Abdirad et al. Diagnostic Pathology 2007 2:25   doi:10.1186/1746-1596-2-25

Open Data